KALU vs KWR
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
KALU presents a dichotomy between strong growth and deteriorating fundamental health, evidenced by a weak Piotroski F-Score of 3/9. While the stock has seen a massive 195.9% 1-year price surge and maintains a high growth-based intrinsic value of $199.42, it trades at a significant premium to its Graham Number of $88.45. The combination of bearish insider selling, a very weak technical trend (10/100), and high debt-to-equity relative to sector peers suggests the current valuation may be overextended despite strong top-line growth.
KWR exhibits a stark divergence between analyst optimism and fundamental health, headlined by a weak Piotroski F-Score of 2/9. While the company shows strong liquidity (Current Ratio 2.42) and impressive year-over-year earnings growth of 48.6%, current profitability is concerning with a negative profit margin (-0.13%) and negative ROE (-0.18%). The stock is currently viewed as a recovery play, supported by a 'Strong Buy' analyst consensus and a target price of $169.20, but the underlying deterministic health scores suggest significant operational instability.
Compare Another Pair
Related Comparisons
KALU vs KWR: Head-to-Head Comparison
This page compares Kaiser Aluminum Corporation (KALU) and Quaker Chemical Corporation (KWR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.